Study Supports High-Dose RT, Long-Term ADT as Standard for High-Risk Prostate Cancer

MedPage Today) — SAN FRANCISCO — Men with high-risk localized prostate cancer lived significantly longer with dose-escalated radiation therapy (RT) plus long-term androgen deprivation therapy (ADT), according to long-term follow-up from a…
Read More